{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:40:30Z","timestamp":1790178030769,"version":"4.1.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036191","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T20:58:18Z","timestamp":1335905898000},"page":"e36191","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Concordant Signaling Pathways Produced by Pesticide Exposure in Mice Correspond to Pathways Identified in Human Parkinson's Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Seema","family":"Gollamudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Johri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Y.","family":"Calingasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Elemento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1007\/PL00007758","article-title":"Pathoanatomy of Parkinson's disease.","volume":"247","author":"H Braak","year":"2000","journal-title":"J Neurol"},{"key":"ref2","first-page":"1321","article-title":"[Pathophysiology of Parkinson's disease: an update].","volume":"194","author":"L Tremblay","year":"2010","journal-title":"Bull Acad Natl Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"a008862","DOI":"10.1101\/cshperspect.a008862","article-title":"The history of Parkinson's disease: early clinical descriptions and neurological therapies.","volume":"1","author":"CG Goetz","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","article-title":"A tale on animal models of Parkinson's disease.","volume":"26","author":"E Bezard","year":"2011","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0079-6123(10)84002-6","article-title":"Neurotoxic in vivo models of Parkinson's disease recent advances.","volume":"184","author":"JR Cannon","year":"2010","journal-title":"Prog Brain Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/466S8a","article-title":"Parkinson's disease: a model dilemma.","volume":"466","author":"MF Beal","year":"2010","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","article-title":"Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease.","volume":"100","author":"TB Sherer","year":"2007","journal-title":"J Neurochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10863-010-9309-4","article-title":"Effects of rotenone and pyridaben on complex I electron transfer and on mitochondrial nitric oxide synthase functional activity.","volume":"42","author":"A Navarro","year":"2010","journal-title":"J Bioenerg Biomembr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.","volume":"1792","author":"R Banerjee","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1471-4159.2003.01525.x","article-title":"Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction.","volume":"84","author":"J Zhang","year":"2003","journal-title":"J Neurochem"},{"key":"ref11","first-page":"31","article-title":"Paraquat and maneb induced neurotoxicity.","volume":"50","author":"B Thrash","year":"2007","journal-title":"Proc West Pharmacol Soc"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.","volume":"277","author":"AB Manning-Bog","year":"2002","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1289\/ehp.7570","article-title":"Developmental pesticide models of the Parkinson disease phenotype.","volume":"113","author":"DA Cory-Slechta","year":"2005","journal-title":"Environ Health Perspect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-005-0020-2","article-title":"Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.","volume":"7","author":"LB Moran","year":"2006","journal-title":"Neurogenetics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.expneurol.2006.01.008","article-title":"Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.","volume":"199","author":"IR Vogt","year":"2006","journal-title":"Exp Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2005.07.010","article-title":"Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease.","volume":"21","author":"RM Miller","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30195","article-title":"Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms.","volume":"137B","author":"Y Zhang","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e4955","DOI":"10.1371\/journal.pone.0004955","article-title":"A Cross-Study Transcriptional Analysis of Parkinson's Disease.","volume":"4","author":"GT Sutherland","year":"2009","journal-title":"PLoS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e16917","DOI":"10.1371\/journal.pone.0016917","article-title":"Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach.","volume":"6","author":"YJK Edwards","year":"2011","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12033-008-9060-9","article-title":"Gene expression profiles of mouse striatum in control and maneb+paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts.","volume":"40","author":"S Patel","year":"2008","journal-title":"Mol Biotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ntt.2011.02.012","article-title":"Genetic-based, differential susceptibility to paraquat neurotoxicity in mice.","volume":"33","author":"L Yin","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ceca.2009.12.003","article-title":"Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.","volume":"47","author":"DJ Surmeier","year":"2010","journal-title":"Cell Calcium"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson's disease.","volume":"447","author":"CS Chan","year":"2007","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ajmg.b.30509","article-title":"Association studies of 23 positional\/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease.","volume":"144B","author":"AR Morgan","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2010.06947.x","article-title":"Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex.","volume":"115","author":"W Si","year":"2010","journal-title":"J Neurochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09687680802706432","article-title":"Acyltransferases for secreted signalling proteins (Review).","volume":"26","author":"SC Chang","year":"2009","journal-title":"Mol Membr Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2011.05.026","article-title":"Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.","volume":"44","author":"RT Bartus","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1242\/dev.065482","article-title":"Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development.","volume":"138","author":"Q Deng","year":"2011","journal-title":"Development"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1460-9568.2007.05653.x","article-title":"The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.","volume":"26","author":"A Abuirmeileh","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/cdd.2011.158","article-title":"BCL2A1: the underdog in the BCL2 family.","volume":"19","author":"M Vogler","year":"2012","journal-title":"Cell Death Differ"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jsbmb.2010.03.034","article-title":"Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future.","volume":"121","author":"JH White","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10907","DOI":"10.1073\/pnas.0802437105","article-title":"GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein.","volume":"105","author":"CR Scherzer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/cncr.24838","article-title":"Serum amyloid A: a novel biomarker for endometrial cancer.","volume":"116","author":"E Cocco","year":"2010","journal-title":"Cancer"},{"key":"ref34","article-title":"Voltage-gated calcium channels and Parkinson's disease.","author":"MJ Hurley","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1002237","DOI":"10.1371\/journal.pgen.1002237","article-title":"Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee.","volume":"7","author":"TH Hamza","year":"2011","journal-title":"PLoS Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1124\/mol.108.048207","article-title":"Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.","volume":"74","author":"S Guerreiro","year":"2008","journal-title":"Mol Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","article-title":"A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.","volume":"3","author":"TG Lesnick","year":"2007","journal-title":"PLoS Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10540-005-2893-6","article-title":"Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.","volume":"25","author":"A Caricasole","year":"2005","journal-title":"Biosci Rep"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/geno.1994.1061","article-title":"Precise mapping of the brain alpha 2-adrenergic receptor gene within chromosome 4p16.","volume":"19","author":"O Riess","year":"1994","journal-title":"Genomics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","article-title":"Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?","volume":"873","author":"M Thiruchelvam","year":"2000","journal-title":"Brain Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1476-5381.2010.00820.x","article-title":"Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease.","volume":"160","author":"PJ Austin","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease.","volume":"2","author":"B Zheng","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease.","volume":"144","author":"JH Shin","year":"2011","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.","volume":"127","author":"J St-Pierre","year":"2006","journal-title":"Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators.","volume":"1","author":"J Lin","year":"2005","journal-title":"Cell Metab"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/cvr\/cvp365","article-title":"PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress.","volume":"85","author":"F Ali","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/CS20110147","article-title":"Haem oxygenase-1: non-canonical roles in physiology and pathology.","volume":"122","author":"A Grochot-Przeczek","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"ref48","first-page":"643","article-title":"Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1.","volume":"117","author":"WL Chien","year":"2011","journal-title":"J Neurochem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals.","volume":"107","author":"M McMahon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1073\/pnas.0607260103","article-title":"DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.","volume":"103","author":"CM Clements","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2009.03.006","article-title":"Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.","volume":"218","author":"H Bueler","year":"2009","journal-title":"Exp Neurol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1172\/JCI37617","article-title":"Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.","volume":"119","author":"H Xiong","year":"2009","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/hmg\/ddp067","article-title":"The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1.","volume":"18","author":"DA Parfitt","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jmb.2011.06.016","article-title":"The neurodegenerative-disease-related protein sacsin is a molecular chaperone.","volume":"411","author":"JF Anderson","year":"2011","journal-title":"J Mol Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.","volume":"305","author":"AM Cuervo","year":"2004","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bip.21302","article-title":"Hsp70 molecular chaperones and Parkinson's disease.","volume":"93","author":"SN Witt","year":"2010","journal-title":"Biopolymers"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1471-4159.2005.03253.x","article-title":"Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity.","volume":"94","author":"C Cleren","year":"2005","journal-title":"J Neurochem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e18373","DOI":"10.1371\/journal.pone.0018373","article-title":"Wnt5a regulates midbrain dopaminergic axon growth and guidance.","volume":"6","author":"BD Blakely","year":"2011","journal-title":"PLoS ONE"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn2755","article-title":"Emerging roles of Wnts in the adult nervous system.","volume":"11","author":"NC Inestrosa","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI32273","article-title":"Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.","volume":"118","author":"CL Parish","year":"2008","journal-title":"J Clin Invest"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2009.07.014","article-title":"Parkin protects dopaminergic neurons from excessive Wnt\/beta-catenin signaling.","volume":"388","author":"N Rawal","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00001756-199805110-00024","article-title":"Abnormalities of Wnt signalling in schizophrenia\u2013evidence for neurodevelopmental abnormality.","volume":"9","author":"D Cotter","year":"1998","journal-title":"Neuroreport"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"ra65","DOI":"10.1126\/scisignal.2002282","article-title":"Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways.","volume":"4","author":"EM Wexler","year":"2011","journal-title":"Sci Signal"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/humu.21394","article-title":"Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration.","volume":"32","author":"SC Lenzken","year":"2011","journal-title":"Hum Mutat"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1212\/01.wnl.0000277638.63767.b8","article-title":"Are Parkinson disease patients protected from some but not all cancers?","volume":"69","author":"R Inzelberg","year":"2007","journal-title":"Neurology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq.","volume":"5","author":"A Mortazavi","year":"2008","journal-title":"Nat Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:34:46Z","timestamp":1713926086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036191"}},"subtitle":[],"editor":[{"given":"Christian","family":"Wider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036191","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}